Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin Antagonist in CHF patients undergoing Exercise) trial.

Russell, Stuart D., Selaru, Paulina, Pyne, David A., Ghazzi, Maha M., Massey, Kenneth D., Pressler, Milton, Serikoff, Alexis and Coats, Andrew J. S. (2003) Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin Antagonist in CHF patients undergoing Exercise) trial. American Heart Journal, 145 (1). pp. 179-186. ISSN 1097-6744

Full text not available from this repository.

Item Type:	Article
Faculty \ School:
Depositing User:	EPrints Services
Date Deposited:	25 Nov 2010 11:13
Last Modified:	24 Oct 2022 03:02
URI:	https://ueaeprints.uea.ac.uk/id/eprint/15430
DOI:	10.1067/mhj.2003.39

Actions (login required)

View Item